Efficacy and Safety Study of DHA-O in Adults With Hypertriglyceridemia

Completed · Not applicable · Has a placebo group

Conditions studied: Hypertriglyceridemia

In brief

The purpose of this study is to investigate the efficacy and safety of DHA-O to lower elevated triglyceride levels in healthy adults with hypertriglyceridemia.

Key facts

Study ID

NCT01737099

Run by

dsm-firmenich Switzerland AG

People needed

93

Starts

2012-11-01

Expected to finish

2013-11-01

Last updated by the study team

2014-04-25

Who can join

Age: 18 and older, up to 79. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• ages 18-79
• fasting TG levels, 150-499 mg/dL
• baseline DHA intake <200mg/d
• active and in good health

You may not qualify if…

• recent diagnosis of CHD or history of revascularization within 6mos of study
• use of lipid altering medications (other than stable statins)
• use of anticoagulants
• use of omega-3 products within 4 weeks of screening
• serum AST/ALT >1.5x ULN and/or creatinine >1.5 mg/dL at screening
• lipid altering foods or supplements
• women who are pregnant or of childbearing potential not using adequate birth control
• current use or history of drug or alcohol abuse
• inability to swallow capsules

Where it is running

• Biofortis Clinical Research — Addison, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.